The weekly litigation news digest is live. Subscribe now

IP Verse

Combination Therapy For The Treatment Of Cancer - EP3033086

The patent EP3033086 was granted to Novartis on Sep 22, 2021. The application was filed on Aug 7, 2014 under application number EP14752433A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3033086

NOVARTIS
Application Number
EP14752433A
Filing Date
Aug 7, 2014
Status
Granted And Under Opposition
Aug 20, 2021
Publication Date
Sep 22, 2021
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (5)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status
BACHELINJun 22, 2022HOFFMANN EITLEADMISSIBLE
GENERICS UKJun 21, 2022ELKINGTON AND FIFEADMISSIBLE
HOFFMANN EITLEJun 21, 2022HOFFMANN EITLEADMISSIBLE
STADA ARZNEIMITTELJun 20, 2022HAMM & WITTKOPPADMISSIBLE
TEVA PHARMACEUTICALSJun 20, 2022D YOUNGADMISSIBLE

Patent Citations (13) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
DESCRIPTIONEP0236940
DESCRIPTIONJPH0755930B
DESCRIPTIONUS4978672
DESCRIPTIONWO2007084786
DESCRIPTIONWO2010020675
DESCRIPTIONWO2010029082
DESCRIPTIONWO2011101409
INTERNATIONAL-SEARCH-REPORTWO2011101409
INTERNATIONAL-SEARCH-REPORTWO2013006532
OPPOSITIONWO2010020675
OPPOSITIONWO2011010409
OPPOSITIONWO2011101417
OPPOSITIONWO2013006532

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents